Overview
Amkor Technology Inc. stock surged in early trading after BofA Securities initiated coverage of the semiconductor packaging and test services company with a Buy rating and a $70 price objective. The price target implies roughly 45% upside from the prior session close of $48.40, and the initiation coincided with a notable pre-market uptick that lifted the shares toward $52.70.
BofA’s forecast and valuation
The bank’s analysts project earnings per share of $1.51 in 2025 rising to $3.41 by 2028, which equates to about a 31% compound annual growth rate. BofA attributes this expected improvement to higher factory utilization rates and a strategic shift toward a greater mix of higher-value products. The $70 target is based on a multiple of 21 times BofA’s above-consensus 2028 EPS estimate.
Operational backdrop
Those forward-looking estimates arrived against a backdrop of tangible recent momentum at Amkor. The company reported a record second quarter in 2026, posting $1.9 billion in revenue that beat consensus forecasts and delivering EPS of $0.70, well ahead of the $0.48 consensus. Management’s progress on long-term strategic agreements with TSMC and Nvidia was highlighted as adding visibility to Amkor’s advanced packaging growth runway.
Sector and market context
The advanced packaging segment has benefited from rising demand tied to AI infrastructure, a dynamic reinforced by peer JCET Group’s solid first-half 2026 results. Market breadth was constructive heading into the session: the Nasdaq Composite was advancing close to 1% and the S&P 500 was modestly positive, providing a generally risk-on backdrop for technology-related names.
Market reaction and mechanics
Investors responded to the combination of a high-profile analyst initiation with a materially above-market price target and Amkor’s recent earnings beat. Those elements together appear to have prompted the sharp pre-market rally, pushing the share price well above its recent trading range and reflecting the market’s reception of BofA’s thesis.
Note on data - The coverage initiation, price target, EPS trajectory, Q2 2026 financial results, and the company’s strategic agreements are reported as provided; no additional forecasts or outcomes are assumed beyond those stated.